228 Studies Now Enrolling
Menu
Search
Status
Medical Condition
- Show all (107)
- Allergy, Asthma, & Immunology (1)
- All of Us Research Program - NIH (1)
- Autoimmune Disorders (6)
- Bone & Muscle (1)
- Cancer (65)
- COVID-19 (Coronavirus) (2)
- Diabetes (1)
- Hair and Skin Disorders (2)
- Healthy Volunteers (7)
- Heart Disease (3)
- Kidney Disease (1)
- Lung Disease (4)
- Neurological Disorders (4)
- Obstetrics & Gynecology (2)
- Pediatrics (3)
- Psychiatric Disorders (1)
- Transplant (2)
- Vascular Conditions (1)
Displaying 1 - 1 of 1
Condition: Cancer / Lung Cancer
Investigator: Catherine Shu, MD
Status: Closed
The purpose of this study is to understand more about the combination of amivantamab and lazertinib in non-small cell lung cancer (NSCLC) who have a specific mutation in the EGFR (epidermal growth factor receptor) gene and have not had prior treatment for their disease. The Food and Drug Administration (FDA) has not approved the combination of amivantamab…